University of Wolverhampton
Browse
Collection All
bullet
bullet
bullet
bullet
Listed communities
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

Wolverhampton Intellectual Repository and E-Theses > Research Institutes > Research Institute in Healthcare Science > Sport, Exercise and Health Research Group > Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis

Please use this identifier to cite or link to this item: http://hdl.handle.net/2436/35375
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!



Title: Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis
Authors: Stavropoulos-Kalinoglou, Antonios
Metsios, Giorgos S.
Panoulas, Vasileios F.
Douglas, Karen M. J.
Nevill, Alan M.
Jamurtas, Athanasios Z.
Kita, Marina D.
Koutedakis, Yiannis
Kitas, George D.
Citation: Annals of the Rheumatic Diseases, 3 August 2008: online
Publisher: BMJ Publishing
Journal: Annals of the Rheumatic Diseases
Issue Date: 2008
URI: http://hdl.handle.net/2436/35375
DOI: 10.1136/ard.2008.095596
PubMed ID: 18677010
Abstract: OBJECTIVES: To assess the associations of body mass index (BMI) with modifiable cardiovascular disease (CVD) risk factors in patients with rheumatoid arthritis (RA). METHODS: BMI, disease activity, selected CVD risk factors and CVD medication were assessed in 378 (276 females) RA patients. Patients exceeding accepted thresholds in >/=3 CVD risk factors were classified as having the metabolic syndrome (MetS). RESULTS: BMI independently associated with hypertension (OR=1.28 (95% CI=1.22-1.34); p=0.001), HDL (OR=1.10 (1.06-1.15); p=0.025), insulin resistance (OR= 1.13 (1.08-1.18); p=0.000) and the MetS (OR=1.15 (1.08-1.21); p=0.000). In multivariable analyses, BMI had the strongest associations with CVD risk factors (F1-354=8.663, p=0.000), and was followed by lipid-lowering treatment (F1-354=7.651, p=0.000), age (F1-354=7.541, p=0.000), antihypertensive treatment (F1-354=4.997, p=0.000) and gender (F1-354=4.707, p=0.000). Prevalence of hypertension (p=0.004), insulin resistance (p=0.005) and the MetS (p=0.000) was significantly different between normal, overweight and obese RA patients, and BMI differed significantly according to the number of risk factors present (p=0.000). CONCLUSIONS: Increasing BMI associates with increased CVD risk independently of many confounders. RA-specific BMI cut-off points better identify RA patients at increased CVD risk. Weight-loss regimes should be developed and applied in order to reduce CVD in RA patients.
Type: Article
Language: en
Keywords: Body Mass Index
Obesity
Cardiovascular Disease
Metabolic Syndrome
Weight loss
ISSN: 1468-2060
Appears in Collections: Sport, Exercise and Health Research Group
Exercise and Health
Learning and Teaching in Sport, Exercise and Performance

Files in This Item:
File Description Size Format View/Open
Stavropoulos-Kalinoglou.BMI_CVDrisk.pdf936KbAdobe PDFThumbnail
View/Open

Related articles on PubMed
bullet
Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
da Cunha VR, Brenol CV, Brenol JC, Fuchs SC, Arlindo EM, Melo IM, Machado CA, de Castro Chaves H Jr, Xavier RM
2012 May
bullet
bullet
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.
Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD
2007 Sep
bullet
Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults.
Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee
2003 Dec
bullet
See all 147 articles

All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Fairtrade - Guarantees a better deal for Third World Producers

University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1LY

Course enquiries: 0800 953 3222, General enquiries: 01902 321000,
Email: enquiries@wlv.ac.uk | Freedom of Information | Disclaimer and copyright | Website feedback | The University as a charity

OR Logo Powered by Open Repository | Cookies